DTGCT is a benign synovial neoplasm driven by a chromosomal translocation t (1:2) (p13; q37), resulting in fusion of the COL6A3 promoter region with the CSF1 gene, leading to CSF1 overexpression12,13. Here, CSF1 is linked to synovium neoplasm.